- A simple test analysing urine and vaginal fluid cells could help rule out womb cancer in women with postmenopausal bleeding.
- Researchers said the approach has the potential to “transform care” for thousands of women annually, and could spare patients from “invasive, uncomfortable” tests.
- A study of 1,864 women showed the combined test of urine and vaginal cell samples correctly identified 80 per cent of cancers and had a 98.8 per cent negative predictive value for womb cancer.
- The test detected 95.8 per cent of high-grade, aggressive tumours and picked up 100 per cent of cancers in black women.
- Professor Emma Davidson, of the University of Manchester and honorary consultant in gynaecological oncology at MFT, said: “If further studies confirm these findings in routine practice, this approach has the potential to transform care for thousands of women every year.”
IN FULL
